4 November 2015 - Nucala is not approved for the treatment of other eosinophilic conditions or relief of acute bronchospasm or status asthmaticus.

For more details, go to: https://www.gsk.com/en-gb/media/press-releases/2015/gsk-s-nucala-mepolizumab-receives-approval-from-us-fda/